drug

Mood stabilizer

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Central South University
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NCT04218981—Completed
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
NCT02775864—Completed

KOLs & investigators

1
Wenbin GuoKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Central South University
company
trial
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NA
trial
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
trial
indication
Schizophrenia
indication
Common Mental Disorder
indication
Bipolar Disorder
indication
Schizophrenia
indication
KOL
Wenbin Guo
KOL score 5
person